Signal #135529 · SEC 8-K

$CTOR SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $CTOR filing catalyst

Why did $CTOR trigger an AI stock catalyst alert?

$CTOR triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +2.5/10). Headline: Citius Oncology Reports Positive Quality of Life Data for LYMPHIR at EORTC-CLTG. Key points: - Phase 3 Study 302 showed 32% of heavily pretreated patients achieved clinically meaningful itch reduction sustained for ≥4 weeks. - Data presented orally at EORTC-CLTG Annual Meeting in Berlin. - Supports commercial positioning of LYMPHIR in relapsed/refractory CTCL.

How did $CTOR stock react after the SEC filing?

After the SEC 8-K for $CTOR, observed market reaction: T0 price $0.55. Past moves do not guarantee future results.

Where can I get real-time $CTOR SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CTOR via Telegram and the VIP Web Terminal from €10/month.

$CTOR

$CTOR – Citius Oncology Reports Positive Quality of Life Data for LYMPHIR at EORTC-CLTG

CITIUS ONCOLOGY, INC.

2026-11-04 00:00:00 UTC · SEC 8-K · All $CTOR

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+2.5 / 10)

Phase 3 Study 302 showed 32% of heavily pretreated patients achieved clinically meaningful itch reduction sustained for ≥4 weeks.
Data presented orally at EORTC-CLTG Annual Meeting in Berlin.
Supports commercial positioning of LYMPHIR in relapsed/refractory CTCL.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →